SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-070413
Filing Date
2023-12-14
Accepted
2023-12-14 16:28:38
Documents
51
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mura-20230930.htm   iXBRL 10-Q 1422657
2 EX-31.1 mura-ex31_1.htm EX-31.1 15188
3 EX-31.2 mura-ex31_2.htm EX-31.2 15221
4 EX-32.1 mura-ex32_1.htm EX-32.1 9209
5 EX-32.2 mura-ex32_2.htm EX-32.2 9250
  Complete submission text file 0000950170-23-070413.txt   3697924

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mura-20230930_pre.xml EX-101.PRE 129508
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mura-20230930_cal.xml EX-101.CAL 27774
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mura-20230930_lab.xml EX-101.LAB 172225
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mura-20230930.xsd EX-101.SCH 24829
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mura-20230930_def.xml EX-101.DEF 45419
45 EXTRACTED XBRL INSTANCE DOCUMENT mura-20230930_htm.xml XML 388390
Mailing Address 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380
Business Address 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380 353 1 905 8020
Mural Oncology plc (Filer) CIK: 0001971543 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41837 | Film No.: 231487400
SIC: 2834 Pharmaceutical Preparations